Patho-physiological Studies on Lactic Acid-induced Pulmonary Thrombosis in Rat

Summary

The roles of platelet aggregation and coagulo-fibrinolytic systems in thrombogenesis of lactic acid-induced pulmonary thrombosis in rat were studied using an anti-coagulant, platelet aggregation inhibitor, fibrinolytic or anti-fibrinolytic agents.

In normal rat, heparin (2.5 mg/kg), acetylsalicylic acid (30 mg/kg) and tranexamic acid (100 mg/kg) suppressed specifically coagulation, platelet aggregation induced by collagen or thrombin and fibrinolysis respectively. Urokinase (10,000 units/kg) activated powerfully fibrinolytic system in addition to suppressing slightly platelet aggregation.

The pretreatment with heparin, acetylsalicylic acid or urokinase markedly prevented the formation of thrombus initiated by the infusion of lactic acid at the doses used. Additive effect was also obtained by combined administration of these agents. On the other hand, it was interesting to note that tranexamic acid (100 mg/kg) did not affect the thrombus formation at all despite a potent anti-fibrinolytic effect of this agent.

These results indicate that both platelet aggregation and enhancement of coagulation activity are important factors responsible for the formation of thrombi in DIC, while the fibrinolytic activity in blood seems not to be involved in it. On the basis of the findings, mechanism for triggering activation of coagulation and platelet aggregation is also discussed here.

• References

• 40 Abiko Y, Iwamoto M, and Tomikawa M. 1969; Plasminogen-Plasmin System. V. A stoichiometric equilibrium complex of plasminogen and a synthetic inhibitor. Biochimica et Biophysica Acta 185: 424.
• 41 Al-Mondhiry A, Marcus A. J, and Speat T. H. 1970; On the mechanism of platelet function inhibition by acetylsalicylic acid. Proceedings of the Society for Experimental Biology and Medicine 133: 632.
• 42 Atac A, Spagnuolo M, and Zucker M. B. 1970; Long-term inhibition of platelet functions by aspirin. Proceedings of the Society for Experimental Biology and Medicine 133: 1331.
• 43 Colman R. W, Robboy S. J, and Minna J. D. 1972; Disseminated intravascular coagulation (DIC): An approach. American Journal of Medicine 52: 679.
• 44 Damus P. S, Hicks M, and Rosenberg R. D. 1973; Anticoagulant action of heparin. Nature 246: 355.
• 45 Grottum K. A. 1969; Platelet surface charge and aggregation: Effects of poly electrolytes. Thrombosis et Diathesis Haemorrhagica 21: 450.
• 46 Hamberg M, Syensson J, and Samuelsson B. 1974; Mechanism of the anti-aggregating effect of aspirin on human platelets. The Lancet July 27: 223.
• 47 Hartert H. 1948; Blutgerinnungsstudien mit der thrombelastographie, einen neuen untersuchungsverfahren. Klinische Wochenschrift 26: 577.
• 48 Hattori A, Tsukada T, Ito S, Koike K, Yamamoto M, Shinoda S, and Matsuoka M. 1973 Studies on platelet adhesiveness in glass bead filter method-Scanning electron microscopic observation in von Willebrand’s disease and effect of aspirin, and hemolytic pattern in filter. The Second Congress of the Japanese Society on Thrombosis and Hemostasis, Tokyo, 27.
• 49 Iwamoto M. 1974 Plasminogen-Plasmin System. IX. Specific binding of tranexamic acid to plasmin. Thrombosis et Diathesis Haemorrhagica, in press.
• 50 Norman P. S. 1966; Antiplasmin. Federation Proceedings 25: 63.
• 51 O’Brien J. R. 1968; Effects of salicylates on human platelets. The Lancet April 13: 779.
• 52 Rosenberg R, and Damus P. S. 1973; The purification and mechanism of action of human antithrombin-heparin cofactor. The Journal of Biological Chemistry 248: 6490.
• 53 Salzman E. W. 1963; Measurement of platelet adhesiveness. Journal of Laboratory and Clinical Medicine 62: 724.
• 54 Shio H, and Ramwell P. 1972; Effect of prostaglandin E₂ and aspirin on the secondary aggregation of human platelets. Nature New Biology 236: 45.
• 55 Tomikawa M, Ogawa H, and Abiko Y. 1974; Experimental model of pulmonary thrombosis in rat. Thrombosis et Diathesis Haemorrhagica 31: 86.
• 56 Zucker M. B, and Peterson J. 1962; Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proceedings of the Society for Experimental Biology and Medicine 26: 547.